Former recipient of the Peter Nelson Leukaemia Research Fellowship
In 2019, Dr Laura Eadie was rewarded the Peter Nelson Leukaemia Research Fellowship.
In her first year, she discovered that a drug showed great potential to treat T-cell acute lymphoblastic leukaemia (T-ALL)—a type of leukaemia that is most commonly found in children aged 14 and younger.
Since then, Dr Eadie has continued to focus on how and when this drug can be used, with recent studies showing it is not only effective, but is far safer and has less side effects, which will have a huge difference on those currently going through treatment.
Researchers like Dr Eadie are the key to unlocking a future free from leukaemia and continuing to increase survival rates for generations to come. That’s why it’s so important that we keep momentum going by funding more leukaemia researchers as they work towards the next cancer breakthrough.